Product Description
Overall, the Global Inferior Vena Cava Filter Market was valued at nearly $308 million in 2025. This is expected to increase over the forecast period at a CAGR of 2.1% to reach over $357 million.
The full report suite on the global market for inferior vena cava filters (IVCFs) includes a meticulous examination across seven prominent geographical regions, namely North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia Pacific and Africa. Within each of these delineated regions, a comprehensive scrutiny will be conducted encompassing various facets, including market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2032, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Coronary Stent Market Trends
A growing trend in the global IVCF market is the emphasis on patient-specific solutions and the development of retrievable filters with advanced design features. This trend reflects an increasing awareness of the need to balance the protective benefits against pulmonary embolism with the risks of long-term filter implantation. Manufacturers are focusing on creating filters that offer improved retrievability, lower complication rates and enhanced compatibility with individual patient anatomies, providing safer, more personalized options for patients needing temporary protection from venous thromboembolism.
Global Coronary Stent Market Share Insights
- In 2025, Becton Dickinson held the leading position in the global IVCF and retrieval device market, particularly dominating the retrievable IVCF segment. Its Denali® Vena Cava Filter is available with both femoral and jugular delivery kits and can be placed either retrievably or permanently. The company has discontinued other IVCF models in the U.S., including the Simon Nitinol Filter®, Meridian® Vena Cava Filter, Eclipse® Vena Cava Filter and G2®X Vena Cava Filter, exiting the permanent IVCF segment.
- In 2025, Cook Medical held the second-leading position in the global IVCF and retrievable filter market, showing particular strength in the retrievable IVCF and IVCF retrieval device segments. The company retained a minor presence in the permanent IVCF market, while its retrievable filter portfolio included the Celect™ Platinum and Günther Tulip™ filters. The Günther Tulip™ filter is designed to maintain 50% blood flow even when the vessel is 70% occluded. Both retrievable filters can be extracted via the jugular using Cook Medical’s Günther Tulip™ vena cava filter retrieval system.
- In 2025, Argon Medical was the third-leading competitor in the market. In January 2016, the company acquired the OptionELITE™ Retrievable Vena Cava Filter, along with two additional vascular products, from Rex Medical. Prior to this acquisition, Argon Medical held licenses for these products and managed their distribution. The OptionELITE™ Retrievable Vena Cava Filter is unique as the only IVCF with FDA approval for delivery via the popliteal vein, while also allowing access through the jugular, femoral and antecubital veins. Retrieval of the filter is performed using the Atrieve® Vascular Snare Kit.
Global Coronary Stent Market Segmentation Summary
- Inferior Vena Cava Filter Market – Further Segmented Into:
- Device Type: IVCF, and IVCF Retrieval Device.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
